Ebitda sell-side analyst consensus figures
August 18, 2020
Second quarter 2020 adj. EBITDA, and full year 2020 adj. EBITDA sell-side analysts’ consensus figures.
The consensus figures are based on analysts’ estimates recorded by the Company. The below consensus figures represent the aggregated expectations of sell-side analysts who, to the best of our knowledge, cover Aperam on a continuous basis.
The listed analysts follow Aperam on their own initiative and Aperam is not responsible for their views.
Adj. EBITDA consensus estimates
|Period||Number of sell-side|
|Adj. EBITDA consensus average EUR million|
|FY 2020*||14||Average: EUR 238 million|
Range: EUR 203 million – 278 million
* Data as of August 18, 2020
The sell-side analysts who cover Aperam and whose estimates are included in the Group consensus outlined above are the following:
- Alphavalue (not included for Q2 estimate ; no quarterly figures)
- Bank of America Merrill Lynch
- Credit Suisse
- Degroof Petercam
- Deutsche Bank
- Exane BNP Paribas
- JP Morgan
- Morgan Stanley
- Oddo BHF
- Societe Generale
The consensus estimate is based on estimates, forecasts and predictions made by third party financial analysts and can only be seen as a consensus view on Aperam's results from an outside perspective. Aperam does not accept any responsibility for the quality or accuracy of any individual forecast or estimate. This web page may contain forward-looking statements based on current assumptions and forecasts made by Aperam or third parties. Various known and unknown risks, uncertainties and other factors could lead to material differences between Aperam's actual future results, financial situation, development or performance, and the estimates given here. These factors include those discussed in Aperam's periodic reports available on www.aperam.com, section Investors & Shareholders.